Several reports have indicated that the product of the retinoblastoma gene (Rb) complexes with the transcription factor E2F. We present evidence that the DNA-binding of the Rb-E2F complex involves another cellular factor. Addition of Rb to purified preparations of E2F does not generate an (2, 3, 8, 10, 26) . Interaction of Rb with E2F is particularly interesting, as it provides an insight into the biochemical function of Rb. E2F has been shown to be involved in the regulation of several proliferation-associated genes (5, 18, 25) . Thus, one description of Rb function would be that Rb, by negatively regulating E2F, inhibits the expression of genes associated with cell proliferation.
The retinoblastoma gene is one of the best characterized tumor suppressor genes. The protein encoded by the retinoblastoma gene, Rb, binds several DNA tumor virus oncoproteins (12, 15, 16) including adenovirus ElA, simian virus 40 T antigen, and papillomavirus E7 protein. More recently, Rb has been shown to interact with cellular transcription factors E2F and DRTF, which are regulated by some of these oncoproteins (2, 3, 8, 10, 26) . Interaction of Rb with E2F is particularly interesting, as it provides an insight into the biochemical function of Rb. E2F has been shown to be involved in the regulation of several proliferation-associated genes (5, 18, 25) . Thus, one description of Rb function would be that Rb, by negatively regulating E2F, inhibits the expression of genes associated with cell proliferation.
The interaction between Rb and E2F has been observed in several different situations. Extracts of U937 human promonocytic cell line contain an Rb-E2F complex that binds the E2F cognate sequence (8, 31) . A second piece of evidence that Rb forms a complex with E2F came from a different approach, in which an Rb affinity column selected cellular proteins that specifically recognized an oligonucleotide homologous to the E2F cognate sequence (10) . Again, in a different situation, Rb was isolated from mouse L cells in the form of a cellular complex, E2F-I, that specifically inhibited the DNA-binding activity of E2F by forming an E2F-E2F-I complex (2) . This third example is different from the first two in that it suggests that Rb under certain conditions can inhibit the DNA-binding ability of E2F. One way to reconcile these differences is to postulate the involvement of other proteins in the Rb-E2F interactions; these other proteins would then determine the mode of Rb regulation of E2F activity. Thus, it would be extremely valuable to identify the accessory proteins involved in Rb-E2F interactions and to analyze their roles in Rb function.
To study the interaction of Rb with E2F, we have initiated a detailed analysis using glutathione-S-transferase (GST)-Rb fusion proteins. Data presented here show that the addition of fusion Rb to purified preparations of E2F results in an inhibition of E2F DNA-binding activity. However, addition of these fusion Rbs to cruder preparations of E2F does not cause an inhibition of the DNA-binding activity of E2F; in * 
MATERIALS AND METHODS
Cells and extracts. Mouse L cells and HeLa cells were grown in Spinner culture using supplemented minimal essential medium (GIBCO; BRL) and 5% calf serum. Extracts were prepared by following a previously described procedure (29, 30) .
GST-Rb fusions. pGEX-2T clones containing Rb cDNA and various mutations at the BamHI site were obtained from Bill Kaelin and D. M. Livingston (Harvard Medical School). The clones were transformed into Escherichia coli DH5a. The induction of GST-Rb production and the purification of GST-Rbs were carried out by following a previously published procedure (21) . The purified preparations were analyzed in sodium dodecyl sulfate (SDS)-gels and then stained with Coomassie brilliant blue, and the concentration of Rb was estimated by comparing intensities of bands with those of known standards.
Plasmids. To obtain the pGEM clones of Rb for in vitro transcription-translation, the Rb sequences from the various pGEX-2T constructs were recovered by polymerase chain reaction. GGGAAGCT'TAGCAGGTATGATCCAACAATT AATGATGATT was used as the upstream primer, and GGCGGATCCTCATTTCTCTTCCTTGTTTGAGGTATC CAT was used as the downstream primer. The products of the polymerase chain reaction were digested with HindIII and BamHI and cloned into the HindIII-BamHI sites of pGEM 3Z (Promega).
Assay of E2F. E2F is assayed on the basis of its ability to bind DNA in a sequence-specific manner. The conditions of the assay have been described elsewhere (28) .
Purification of E2F. E2F was purified from uninfected HeLa cell nuclear extracts and from L-cell whole-cell extracts by using a previously described procedure (34) with the following modifications. A Q-Sepharose column was 4328 RAY ET AL.
used in place of the Mono-Q column, and the Q-Sepharosecolumn-purified E2F was further purified through a phosphocellulose column as described before (34) . The phosphocellulose-purified E2F from L-cell extracts was treated with 0.9% deoxycholate followed by 1% Nonidet P-40 as described before (1) . Upon DNA affinity chromatography, such deoxycholate-treated E2F yields E2F preparations that are essentially free of all E2F-binding proteins. Affinity chromatography was carried out as described before (34) . Assay of RBP60. RBP60 is assayed on the basis of its ability to counteract Rb inhibition of E2F and produce a slower migrating complex in gel retardation assays. A typical reaction mixture contained 20 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid; pH 7.6), 50 mM KCI, 1 mM MgCl2, 0.2 mM dithiothreitol, 1 ,ug of salmon sperm DNA, 0.2 ng of a 3'-end-labeled E2 promoter-containing probe (1), about 5 ng of E2F purified from HeLa cells (34), 1 ng of GST-Rb fusion protein, and 2 to 5 ,ul of column fraction in a total volume of 30 pl. The reaction mixtures were incubated at 25°C for 30 min. Ficoll was added to a final concentration of 3% at the end of the incubation, and an aliquot (7 ,ul) was analyzed in gel retardation assays as described before (34) .
Purification of RBP60. Highly purified preparations of RBP60 can be obtained as by-products of E2F-I purification (2) . A large proportion of RBP60 copurifies with E2F-I in heparin-agarose column, ammonium sulfate fractionation, and DEAE-Sepharose chromatographies. RBP60 does not bind to phosphocellulose; as a result, during the purification of E2F-I by phosphocellulose chromatography, E2F-I is recovered from the bound fractions, and RBP60 is recovered from the unbound fraction. The RBP60 activity so obtained from L-cell extracts (from 40 liters of cell) was concentrated by precipitation with ammonium sulfate and further purified by glycerol (7.5 to 30% [vol/vol]) gradient centrifugation.
In vitro translation of Rb. The plasmids (pGEM 3Z) containing Rb sequences at the HindIII-BamHI sites were linearized with BamHI, and capped RNA was made by following a previously described protocol (1) . RNAs were translated in vitro with the reticulocyte lysate kit from Promega Biotechnology.
[s35]tnethionine-labeled full-length translation products were assayed by SDS-polyacrylamide gel electrophoresis and autoradiography.
Far-Western blotting. Far-Western blotting experiments to detect Rb-RBP60 interaction were carried out by following a protocol described before (23) .
RESULTS
DNA binding of the Rb-E2F complex involves another factor. We have used two GST-Rb fusion proteins, pGT-RB(379-928) and pGT-RB(379-928; 706 C-F) (21) . Both of these fusion proteins contain the C-terminal 549 residues of Rb (between residues 379 and 928), but pGT-RB(379-928; 706 C-F) contains a point mutation that results in a replacement of the cysteine residue at position 706 with a phenylalanine. Recent work (17) has shown that a C-terminal 56-kDa fragment of Rb is functionally active and can arrest the cell's progression through the cell cycle at the G1 phase. Thus, for simplicity, we will refer to pGT-RB(379-928) as wild type. The point mutant described above [pGT-RB(379-928; 706 C-F)] is a loss-of-function mutant and does not bind DNA tumor virus oncoproteins (21) . Also, it has been shown that this mutant is phosphorylation defective (22) . As described below, the wild-type and mutant GST-Rb fusion . Heparin-agarose-purified E2F (HA; 5 ,ug), 0.05 ,ug of phosphocellulose-purified E2F (PC), or a few nanograms of affinity-purified E2F (AFF) was incubated with GST-Rb fusion proteins in a reaction mixture that contained components required for the sequence-specific DNA binding of E2F (see Materials and Methods) in a total reaction volume of 30 ,u. At the end of a 30-min incubation at 25°C, aliquots (7 pJ) were analyzed by gel retardation assays as described before (28) . The faster migrating band probably represents partially proteolyzed E2F. proteins were added to E2F at different stages of purification ( Fig. 1) .
We have purified E2F from extracts of HeLa cells and L cells by following a procedure described previously (34; see also Materials and Methods above) with slight modifications. The extracts were fractionated successively through heparin-agarose, Q-Sepharose, phosphocellulose, and an E2F-binding site-specific affinity column (for details, see reference 34). L-cell extract E2F, which has the same size and binding specificity as HeLa cell E2F (1), purifies as a cyclin A-E2F complex through the phosphocellulose column (data not shown). This complex is dissociated with deoxycholate (1) before it is applied to the affinity column. This step yields E2F that is free of the binding proteins. As can be seen in Fig. 1 , these various preparations of E2F interact with Rb to produce different results.
Addition of the wild-type GST-Rb fusion protein to cruder preparations of E2F, for example, the heparin-agarosepurified E2F (Fig. 1A) , induced formation of a complex, E2Fr, at the expense of the E2F-DNA complex. However, addition of the same amount of the wild-type GST-Rb to either phosphocellulose-purified (Fig. 1B) or affinity-purified ( Fig. 1C and D) E2F did not produce the E2Fr complex, and in fact, Rb inhibited the DNA-binding activity of E2F. The affinity-purified L-cell E2F and HeLa-cell E2F behaved similarly in these assays. The Q-Sepharose-purified E2F from HeLa cells exhibited an intermediate phenotype (data not shown). In this experiment, we used 10 ng of GST-Rb; however, we got the same result with 5 ng of GST-Rb. These effects of Rb on E2F are not nonspecific, because addition of GST-Rb had no effect on the DNA-binding activity of another transcription factor, E4F (data not shown).
Thus, there are two major differences between purified E2F and E2F in the crude extracts. First, E2F in the crude extracts is protected from Rb inhibition, and second, E2F in the crude extracts forms a complex with Rb that binds DNA and migrates differently from the E2F-DNA complex in gel retardation assays. These results suggest that cruder preparations of E2F contain activities that allow formation of an Rb-E2F-DNA complex. A similar suggestion is made by Hiebert et al. (18a) on the basis of experiments using Mono-Q-purified and affinity-purified E2F preparations. In those experiments, the Mono-Q-purified preparation of E2F produced an Rb-E2F complex that bound DNA, whereas the affinity-purified preparation failed to produce such a complex. We included a phosphocellulose chromatography step in our E2F purification procedure before performing an affinity column step. E2F purified in this manner does not form an Rb-E2F-DNA complex; moreover, we also find that Rb inhibits the DNA-binding ability of E2F. This is consistent with our previous observation that Rb copurifies with an inhibitor, E2F-I, that inhibits the DNA-binding activity of E2F. The extent of Rb inhibition of the DNA-binding activity of E2F varies with preparations of purified E2F. However, purified E2F was reproducibly unable to form the E2Fr complex.
Identification of cellular activity, RBP60, that induces formation of the E2Fr complex. Since we routinely fractionate L-cell extracts, various column fractions obtained from such extracts were assayed for an activity that would produce the E2Fr complex. The column fractions were assayed in reaction mixtures that contained purified E2F, pGT-RB(379-928), and a specific DNA probe along with other components required for E2F-specific DNA binding. L-cell extracts were first fractionated by heparin-agarose chromatography, and the 0.25 M eluate of this column was then fractionated by ammonium sulfate and DEAE-Sepharose chromatography as described before (2) . In the course of these fractionations, we identified an activity, RBP60, that blocked Rb inhibition and cooperated with the wild-type Rb (lane 5, Fig. 2 ) but not with a mutant Rb, pGT-RB(379-928; 706 C-F) (lane 7, Fig. 2) , to induce the formation of the E2Fr complex. Moreover, as can be seen in Fig. 2 , the reconstituted Rb-E2F complex is regulated by adenovirus ElA protein. Addition of GST-ElA dissolved the E2Fr complex and released free E2F (lane 9, Fig. 2) . Thus, this reconstituted Rb-E2F complex behaves similarly to the ElA-regulated Rb-E2F complex present in the extracts of the U937 promonocytic cell line (8) .
A large proportion of the RBP60 activity copurifies with E2F-I activity in heparin-agarose, ammonium sulfate fractionation, and DEAE-Sepharose chromatographies (data not shown). RBP60 was separated from E2F-I during chromatography through a phosphocellulose column. E2F-I binds to phosphocellulose (2) , and all RBP60 activity was detected in the flowthrough material of this column (data not shown). The RBP60 at this step is usually over 70% pure, because most of the proteins applied to phosphocellulose bind to the column. The phosphocellulose-purified material was further purified by glycerol gradient centrifugation. Figure 3 shows results of this purification procedure. Figure 3A shows an assay for RBP60 activity, and Fig. 3B shows a silver-stained SDS-gel of the gradient fractions. Clearly, fractions 12, 13, 14, and 15 contained the RBP60 activity that blocked Rb inhibition and produced the E2Fr complex. Also, the RBP60 activity sedimented slightly slower than bovine serum albu- min, indicating that the native molecular weight of RBP60 is slightly less than that of bovine serum albumin. We also see increases in the levels of E2F-DNA complex in fractions 12, 13, 14, and 15. These increases in the E2F-DNA complex most likely result from the breakdown of the E2Fr complex. As can be seen in Fig. 3B , the major protein in the active fractions of the purified RBP60 is a 60-kDa polypeptide. We also detected a minor band of 57 kDa. We believe that the 57-kDa band is a breakdown product of the 60-kDa band, as digestion of these two polypeptides with CNBr produced almost identical band patterns (data not shown). Further- 3 . Purification of RBP60. RBP60 activity was purified from L-cell extracts by heparin-agarose, ammonium sulfate, DEAESepharose, and phosphocellulose chromatographies and finally by glycerol gradient centrifugation (as described in Materials and Methods). (A) Assay of RBP60 activity in fractions obtained from the glycerol gradient. An aliquot (3 ,ul) of the indicated fractions was assayed in the presence of 10 ng of wild-type Rb and affinity-purified E2F as described in the text. A separate glycerol gradient was run with standard molecular weight marker proteins. Peak fractions, containing bovine serum albumin (BSA) and aldolase, are indicated at the top with arrows. (B) SDS-polyacrylamide gel analysis of the glycerol gradient fractions. Aliquots (50 ,u) of the indicated fractions were subjected to 10% SDS-polyacrylamide gel electrophoresis followed by silver staining. The first lane at the left shows the migrations of molecular weight markers. more, the experiment whose results are shown in Fig. 3 also shows that the 60-kDa polypeptide comigrates with the RBP60 activity during glycerol gradient centrifugation (compare Fig. 3A and B) . Thus, on the bases of the sedimentation property of RBP60, SDS-gel analysis, and copurification of the 60-kDa band with the RBP60 activity during glycerol gradient centrifugation, we conclude that the 60-kDa polypeptide represents the RBP60 activity. E2Fr complex induced by purified RBP60 contains Rb. We then tested to see whether the E2Fr complex induced by purified RBP60, purified E2F, and Rb contains Rb as a component of the complex. To do this, the E2Fr complex was first formed with purified L-cell E2F (lanes 1 to 3, Fig.  4) or purified HeLa-cell E2F (lanes 4 to 6, Fig. 4) . The complexes were then further incubated alone, with an Rbpeptide antiserum (RB-Ab2; Oncogene Science) or with a control antiserum (fos-Ab2; Oncogene Science). As can be seen in Fig. 4 , Rb-specific antiserum specifically recognizes the E2Fr complex and causes a further retardation of that complex in a mobility shift assay. This suggests that the E2Fr complex contain Rb as a component. The control antiserum had no effect on the E2Fr complex (lanes 2 and 4, Fig. 4) . GST-E1A fusion proteins GST-12SE1A and GST-12SE1A(CR1) were used in this experiment. The construction of plasmid-encoding GST-12SE1A has been described before (2) . The plasmid encoding GST-12SE1A(CR1) was constructed by following a similar protocol except that an ElA plasmid bearing a deletion corresponding to amino acids 38 to 67 of ElA (27) was used as template in the polymerase chain reaction. We always get partial degradation of the ElA fusion proteins during purification by using a standard protocol. The wild-type construct (GST-12SE1A) produces two bands (66 and 46 kDa) in a Coomassie-stained SDS-gel, and the mutant [GST-12SELA(CR1)] produces two bands of 63 and 50 kDa. The 66-and 63-kDa bands represent the full-length products. ElA fusion proteins (6 ,ug in each lane) were applied for 10% SDS-gel electrophoresis followed by electroblotting to nitrocellulose. Lanes RBP60 is an Rb-binding protein. We then investigated how RBP60 counteracts Rb inhibition and induces formation of the E2Fr complex. A titration experiment (not shown) with increasing amounts of RBP60 suggested that the reaction involved in the formation of the E2Fr complex was noncatalytic and most likely involved physical association of the components. RBP60 alone, when added to E2F, did not alter the mobility of the E2F-DNA complex in gel retardation assays (Fig. 2, lane 2) . This observation suggests that RBP60 most likely does not interact with E2F directly and that the formation of the E2Fr complex may involve an interaction between Rb and RBP60. Attempts to see a specific interaction between Rb and RBP60 by using GST-Rb fusion protein linked to glutathione-Sepharose were blurred by nonspecific binding of RBP60 to the glutathione-Sepharose beads (data not shown). However, the availability of s35-labeled Rb allowed us look for a direct interaction between Rb and RBP60 by using the far-Western method (23) .
Appropriate pGEM clones encoding amino acid residues 379 to 928 of Rb (WT-RB) or with a point mutation (MU-RB;
replacement of cysteine with phenylalanine at residue 706) were used to produce s35-labeled Rb by using SP6 polymerase and reticulocyte lysates (data not shown). The s35-labeled Rbs were then used to probe protein blots containing RBP60 or a known Rb-binding protein, ElA, by following the protocol described before (23) . Briefly, the protein samples were separated by SDS-gel electrophoresis and then blotted onto a nitrocellulose membrane. The nitrocellulose blot was denatured and renatured by sequential treatment with 6 M guanidine hydrochloride and 0.1 M guanidine hydrochloride as described before (23 (Fig. SB) . In this experiment, RBP60 purified by the phosphocellulose step was used. Clearly, wild-type Rb recognized RBP60 (Fig. SB, lane 1) , and mutant Rb was significantly impaired in its ability to bind RBP60. Moreover, when a series of polypeptides including phosphorylase b (2 ,ug), bovine serum albumin (2 ,ug), ovalbumin (2 p,g), and carbonic anhydrase (2 ,ug) was probed simultaneously with RBP60 (0.5 p,g), only RBP60 was recognized by Rb. These results suggest that Rb can specifically interact with RBP60. 
DISCUSSION
The studies of Rb regulation of E2F activity have significant impact on our understanding of the biochemical function of Rb and Rb-mediated tumor suppression. E2F-binding sites are present in the promoters of several proliferationassociated genes (5, 25) . E2F sites in the promoters of c-myc and dhfr have been shown to regulate expression of these genes (5, 18) . Negative regulation of E2F activity by Rb would prevent expression of these proliferation-associated genes, which in turn would inhibit cell proliferation. We recently identified an inhibitor, E2F-I, that specifically inhibits the DNA-binding activity of E2F (27) . Moreover, we also showed that Rb is an integral part of this inhibitory activity (2) . Here, we show that Rb produced in bacteria can inhibit the DNA-binding activity of E2F. The bacterially produced GST-Rb fusion protein is much less active than E2F-I in that it cannot inhibit E2F in crude extract, and again, the extent of the inhibition obtained with purified E2F varies from 60 to 90%. The reason for this difference between Rb and E2F-I is not clear.
We also find that adding Rb to crude extracts induces the formation of a new E2F-containing complex, E2Fr . This suggests that the crude cellular extracts contain proteins that allow the Rb-E2F complex to bind DNA. We have fractionated mouse L-cell extracts and looked for activities that would allow formation of the E2Fr complex. These fractionations resulted in the identification of a factor, RBP60, that apparently contains two properties; that is, it can block Rb inhibition and at the same time can induce the formation of the E2Fr complex. We have not been able to separate these two activities; they copurify as a single entity with RBP60. One explanation for these phenomena is that Rb can form a binary complex with E2F and that this binary complex has a lower affinity for DNA; addition of RBP60 produces a ternary complex which has higher affinity for DNA, and this DNA complex (E2Fr) has a mobility that is distinct from that of the simple E2F-DNA complex. Support for this explanation comes from the purification and characterization of RBP60.
Several Rb-binding proteins have been identified (13, 20, 21) . However, their biochemical functions have yet to be determined. By doing biochemical assays, we have identified a 60-kDa Rb-binding protein that appears to modulate Rb regulation of the DNA-binding activity of E2F. Although a direct interaction between Rb and E2F has yet to be shown, we find that bacterially produced Rb can interact with the most purified preparations of E2F, leading to an apparent loss of the DNA-binding activity of E2F, and we speculate that this Rb-E2F interaction involves formation of a binary complex containing Rb and E2F. RBP60 reverses the inhibitory effect of Rb and induces the formation of a complex, E2Fr , that binds DNA and in gel retardation assays migrates slower than a simple E2F-DNA complex. Given the facts that the formation of the E2Fr complex is dependent on E2F, Rb, and RBP60 (Fig. 2) and that this complex contains Rb (Fig. 4) along with the observation that RBP60 is an Rbbinding protein, it is quite likely that the E2Fr complex contains all three components.
It has been suggested that the function of Rb is regulated by phosphorylation (6, 9, 11, 24) . Several lines of evidence (11) indicate that Rb is hyperphosphorylated at the G1-S boundary of the cell cycle and that the hyperphosphorylated Rb is functionally inactive. However, more-recent experiments (17) indicate that the regulatory function of Rb is inactive after a certain restriction point in the G1 phase of the cell cycle and that this restriction point occurs long before the time at which Rb becomes hyperphosphorylated. Microinjection of Rb after the restriction point had no inhibitory effect on cells' progression through the cell cycle. This suggests that the growth-inhibitory function of Rb can be neutralized by mechanisms other than phosphorylation. This is interesting in light of our observation that extracts from growing cells contain a factor, RBP60, that protects targets such as E2F from Rb inhibition.
It is quite likely that the inhibitory function of Rb is regulated at two levels. The first level may involve specific interaction of Rb with regulatory proteins, for example, RBP60. In the absence of RBP60, Rb-E2F complex does not bind DNA, and the addition of RBP60 stimulates the DNAbinding activity of an Rb-E2F complex, most likely by interacting with Rb. One attractive model would be that this is a mechanism by which Rb is localized on the DNA for the second level of regulation, which is hyperphosphorylation. In this regard, it is interesting to note that a cell cycleregulated kinase that can potentially phosphorylate Rb is also localized to the DNA by the same transcription factor, E2F (7, 14, 31) and that E2F-binding sites are present in multiple copies in cellular promoters (25) .
DRTF, an E2F-related factor, has been shown to interact with Rb dependent on cyclin A (3, 4). We, however, have not seen any indication of cyclin A in the E2Fr complex. The purified RBP60 is not recognized by antiserum raised against cyclin A. On the other hand, it is quite possible that RBP60 represents other type of cyclins, especially the G1 cyclins (19) . Clearly, further analysis of RBP60 will be valuable in this regard.
